Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
This summary evaluates the association between MTF2 and Parkinson disease based on large-scale genetic association studies and supporting functional evidence. A multi-ancestry meta-analysis involving 49,049 cases (PMID:38155330) and an independent study analyzing prodromal patients (PMID:38732343) identified MTF2 among 12 novel loci with genome‑wide significant signals. The robustness of these observations is enhanced by the substantial sample sizes and the replication of associations across diverse populations. Such data underpins a gene‑disease association rating of Strong. The clinical reports enrich the data by highlighting risk estimates in both typical and prodromal stages of the disease.
Genetic evidence is supported by the identification of MTF2 as a potential risk gene in large case‑control cohorts. Although no individual coding variant meeting strict HGVS criteria was provided in the reports, the overall association signal remains persuasive given the wide representation of cases and the discovery of multiple independent loci. While segregation data was not explicitly detailed, the breadth of the studies indirectly supports the cumulative genetic contribution of MTF2 to Parkinson disease risk. These analyses suggest that the genetic evidence is robust and reproducible across different cohorts.
Experimental studies provide complementary but indirect support for the role of MTF2. Functional assays, such as those reported in The Biochemical Journal (PMID:9173905), demonstrate that MTF2 encodes a Zn2+-regulated transcription factor (formerly referred to as ZiRF1) with specific binding activities at metal‑responsive elements. This modulation of transcriptional activity may be relevant to neuronal function and survival, though direct links to Parkinson disease pathogenesis require further elucidation. The functional evidence is thus rated as Moderate because the experimental findings are consistent with a regulatory role but do not fully recapitulate the neurological phenotype.
The integration of extensive genetic association data and functional insights provides a coherent narrative supporting the involvement of MTF2 in Parkinson disease. The large scale of the genetic data, with tens of thousands of cases, demonstrates a strong statistical signal even in the absence of classical Mendelian segregation. The functional studies, while not directly testing neuronal outcomes, contribute to a mechanistic understanding that may be pertinent to the disease process. Further studies are anticipated to refine the mechanistic link and explore potential therapeutic targets.
Moreover, despite the absence of explicit coding variants in the provided evidence, the collective findings from independent genetic studies justify a clinical-validity categorization as Strong. These studies, conducted in diverse populations with independent replication, support the incorporation of MTF2 into diagnostic and prognostic panels for Parkinson disease. The observed associations are clinically useful, providing a basis for genetic screening and risk prediction in a complex disease context.
Key take‑home sentence: The robust genetic association of MTF2 with Parkinson disease, confirmed by large‐scale multi-ancestry studies, offers clinically actionable insights that underscore its potential utility in diagnostic decision‑making and future therapeutic research.
Gene–Disease AssociationStrongLarge multi‑ancestry meta-analysis with 49,049 cases (PMID:38155330) and supportive prodromal PD data (PMID:38732343) substantiate a strong association. Genetic EvidenceStrongMTF2 was consistently identified among 12 novel loci across diverse populations, underscoring robust genetic evidence despite the absence of individual coding variants. Functional EvidenceModerateExperimental assays demonstrate that MTF2 functions as a Zn2+-regulated transcription factor, supporting a potential mechanistic role in disease pathogenesis, although direct neuronal correlations remain to be established. |